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Summary: The determination of norepinephrine and epinephrine in plasma by HPLC with amperometric
detection was modified, giving detection limits of 25 ng/1 and 18 ng/1 for norepinephrine and epinephrine,
respectively, using l ml plasma. In order to achieve this sensitivity,* it was necessary to minimize the
background noise by modification of Instrumentation and specimen handling. Particularly important was
the extra purification of the reagents, the application of micro-bore HPLC, the enzymatic cleavage of uric
acid and temperature control of the amperometric cell and the amplifier. Comparison of the present method
with the radioenzymatic determination of catecholamines resulted in coefficients of correlation of r = 0.924
and 0.919 for norepinephrine and epinephrine, resp. (n = 38). The concentrations of the 38 different samples
used for the comparison were in the physiological ränge.
Bestimmung der Katecholamine im Plasma durch HPLC und amperometrische Detektion — Vergleich mit einer
radioenzymatischen Methode
Zusammenfassung: Die Bestimmung von Noradrenalin und Adrenalin im Plasma mit HPLC und amperome-
trischer Detektion wurde so modifiziert, daß — bei einem Probenvolumen von l ml Plasma — eine Nachweis-
grenze von 25 ng/1 für Noradrenalin und von 18 ng/1 für Adrenalin erreicht würde. Diese Empfindlichkeit
konnte durch Erniedrigung des Untergrundrauschens erreicht werden, indem die Meßapparatur und die
Probenaufarbeitung modifiziert wurden. Besonders wichtig sind hierbei die Reinigung der verwendeten
Reagenzien, die Verwendung von „micro-bore"-Säulen, die enzymatische Spaltung der Harnsäure sowie die
Temperierung der amperometrischen Zelle und des Verstärkers. Bei dem Vergleich der hier beschriebenen
Methode mit der radioenzymatischen Methode ergaben sich Korrelationskoeffizienten von r = 0,924 und
0,919 für Noradrenalin und Adrenalin (n = 38), wobei die Katecholaminkonzentrationen in allen Proben im
physiologischen Bereich waren.
n o uc on plasma are used. Moreover, there are great differen-
The determination of catecholamines in plasma by ces in the concentrations determined by HPLC with
HPLC and amperometric detection has been de- amperometric detection versus those measured with
scribed by several authors (for review see 1. c. (1—6). a radioenzymatic method (7). The aim of the present
They have used sample volumes ranging from 0.75 study was the development of a method for the deter-
to 4 ml of plasma for each determination, The sensi- mination of norepinephrine and epinephrine in
tivity of these methods is inadequate for determina- plasma which combines both simple handling and
tion of resting values of epinephrine, even if 4 ml of sufficient sensitivity.
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This goal seemed to be reasonable in view of the fact
that an electrochemical method requires no tritiated
compounds and is more amenable to mechanization
(thereby increasing sample frequency) than the time
consuming radioenzymatic method.
Methods
Principle of the method
The catecholamines are separated from the plasma matrix by
adsorption on alumina at a high pH followed by selective
desorption using a mixture of boric and acetic acid. The Separa-
tion and quantification of the extracted catecholamines is per-
formed by micro-bore HPLC with amperometric detection. As
uric acid is eluted at the front of the chromatogram, the
enzymatic cleavage of uric acid is performed to avoid interfer-
ence with norepinephrine.
Equipment
Details of the measuring equipment have been described by
Bauersfeld et al. (8).
Chemicals and reagents
Alumina, neutral 70—200 mesh (Merck, Darmstadt), was puri-
fied and activated s described by Anton & Sayre (9). Sodium
sulphate p. a. (Merck) was extracted with a solution of dithizon
in Chloroform to remove traces of heavy metals. Boric acid
p. a. (Merck): a saturated solution of boric acid was extracted
with ethyl acetate and recrystallised. Water was purified.by
distilling over sodium permanganate. Solutions were prepared
acc. to Bauersfeld et al. (8).
Methodology
To l ml of plasma were added 100 μΐ of solution B (8), 100 μΐ
of 2 mol/1 Tris solution and 50 μΐ of 20 U/l uricase solution.
After 10 min, 10 mg of alumina were added and cautiously
mixed for 15 min using an inverting mixer. Next, the samples
were centrifuged at 15000g for 30s. The upper layer was
aspirated and discarded. The alumina was then washed twice
with 500 μΐ of solution F. A final washing was performed with
500 μΐ of water. Following centrifugation, the washing solution
was drawn off once again.
Following the addition of 50 μΐ of solution E, the samples were
agitated for 5 min, then centrifuged at 15000g for 2 min, after
which each solution was transferred to another Eppendorf vial.
These eluates were then stored at 4 °C until HPLC measure-
ment. A final centrifugation at 15000g for 2min was per-
formed immediately preceding injection of 20 μΐ of the eluates.
The HPLC Separation was performed using a micro-bore col-
umn; mobile phase: 42 mmol/1 acetic acid, l mmol/1 butylamine,
0.8 mmol/1 sodium octylsulphonate, 0.05 mmol/1 disodium-
EDTA, 10 mmol/1 sodium sulphate. The flow rate was 300 μΐ/
min. The amperometric detector was set to an oxidizing poten^
tial of 650 mV and a sensitivity of 0.5 nA at f ll scale. The
recovery of each sample was determined using the peak heights
of the internal Standards (3,4-dihydroxybenzylamine or epin-
ine).
Radioenzymatic method
For the comparative radioenzymatic measurements the method
of Ratge et al. (10) was used.
Results and Discussion
The within-run and between-run precision was esti-
mated by n = 10 measurements of plasma samples
containing the catecholamines in physiological con-
centrations (tab. 1). The results are c mparable to
those obtained with the radioenzymatic method used
routinely in our laboratqry (10). The recovery of
norepinephrine was 99.1% (r nge 83.1 —106.9%) and
of epinephrine 96.0% (r nge 88.2-109.3%). The lin-
ear measuring r nge was 40 to 1200 ng/1 for norepi-
nephrine and 20 to 1200 ng/1 for epinephrine, resp.
Thirty eight different serum samples were analysed
with the present method and with the radioenzymatic
method. The concentration of catecholamines in these
samples were in the physiological r nge. The results
of the comparison are shown in figures l a and l b.
Statistical evaluation resulted in a regression line of
y = 0.924 χ + 5.5 ng/1 (r = 0.921) for norepi-
nephrine and y = 0.919 χ + 2.8 ng/1 (r = 0.923) for
epinephrine (x = radioenzymatic method).
Tab. 1. Within nm and between day precision of the plasma
catecholamine determination by HPLC combined with
amperometric detection.
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A large n mber of compounds were added, in order
to evaluate their potential interference with the.deter-
mination of norepinephrine and epinephrine. No
interference by any of the tested compounds (norme-
tanephrine, metanephrine, 3-methoxytyramine, 3-me-
thoxy-4-hydroxyphenylglycol, vanilmandelic acid,
homovanillic acid, tyramine, octopamine, synephrine,
3,4-dihydroxymandelic acid, 3,4-dihydroxyphenyl-
alanine, 3,4-dihydroxyphenylglycol, serotonin, kynu-
renine, 3-hydroxykynurenine and tryptamine) was
observed.
Sensitivity
The detection limit was estimated to be 25 ng/1 and
18 iig/1 for norepinephrine and epinephrine, resp.,
when defmed s the concentration equivalent to three
times the baseline noise. * *
J. Clin. Chem. Clin. Biochem, / Vol. 24,1986 / No. 3






100 500 1000 1500
Norepinephrine (radioenzymatic method) Cng/U
50 100 150 200 250
Epinephrine (radioenzymatic method) T n g / U
300
Fig. 1. Comparison of the detennination of norepinephrine (l a) and epinephrine (Xb) by HPLC and amperometric detection
(ordinate) with a radioenzymatic method (abscissa).
y a= 0.924 -f 5.5 ng/1, r = 0.921, n = 38 (norepinephrine)
y = 0.919 -l· 2.8 ng/1, r = 0.923, n = 38 (epinephrine)
To compare the sensitivity of our method with that
of other publications that define the detection limit
äs three times the baseline noise of aqueous catechol-
amine Solutions, we obtained values of 3.5 pg norepi-
nephrine and 4.0 pg epinephrine, for the detection
limits.
Practicability
The time required for each chromatogram was 30
min. The sample freqüeiicy was determined to be 40
samples/day, presuming the use of a programme-
controlled sample injeetor. Pre-purification of 12
samples required about one hour and the evaluation
of the chromatograms an additional hoür.
Clinical application of the method
The· sensitivity of the presented method is adequate
for measuring norepinephrine and epinephrine in the
ränge of physiolpgical plasma concentrations. A typi-
cal chromatogram of a sample frpm a healthy volun-
teer is shown in figure 2 (left). The marked peaks
correspond to concentrations of 194 ng/1 and 57 ng/1
of norepinephrine and epinephrine, resp. A chroma-
togram of a sample from a patient with a phaeochro-
mocytoma is shown in figure 2 (right). The peaks
correspond to concentrations of 1292 ng/1 and 1023
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Fig. 2. Typical chromatograms obtained by the present
method.
Left: Chromatogram of a healthy vohmteer (194 ng/i
norepinephrine, 57 ng/1 epinephrine).
Right: Chromatogram of a patient with a phaeochro-
mocytoma (1292 ng/1 norepinephrine, 1023 ng/1 epi-
nephrine).
In the first part of the second chromatogram the sensi-
tivity of the detector was reduced to an amplification
ratio of20%.
(E = epinephrine; NE = norepinephrine;
DA = dopamine; EPI = Epinine;
DHBA = 3,4-dihydroxybenzylamine).
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The increase in sensitivity of the present method
results from several modifications to instrumentatipn
and handling. The use of a micro-bore column per-
mitting low flow rates, of a detector capable of con-
trolling the temperature of the thin layer cell, and
of an amplifier generating reduce.d electronic noise
results in a significant increase in the sensitivity of
the method. As the Separation of norepinephrine
from uric acid by HPLC is generally difficult, enzym-
atic cleavage of uric acid is utilized to avoid this
Chromatographie problem. The elution of catechol-
amines from alumina by a mixture of boric and acetic
acid also increases the selectivity of the method. This
is demonstrated by the fact that the interferences with
epinephrine and 3,4-dihydroxybenzylamine which
can be observed by elution with perchloric acid, are
not observed when a mixture of boric acid and acetic
acid is employed.
Dual electrochemical detectors (11) may be more
selective than simple amperometric detectors, but it
was impossible to separate interferants like uric acid
in this way.
The excellent correlation of the two methods evalu-
ated in the present study demonstrates the necessity
of the described modifications.. (It should also be
remembered that each measurement presented in this
study was accomplished using a sample volume of
l ml, which is a quarter of the volume required in
most previously published procedures.
Another advantage of this method is the simplified
handling compared with radioenzymatic methods. A
sample frequency of 40 samples per day can be achi-
eved with 8 hours being needed for the pre-purifica-
tion of the samples and the final evaluation of the
chromatograms. If samples from differeiit patients
are estimated by the radioenzymatic method, enzym-
atic recovery must be determined for each sample,
and oiily 25 samples can be measured in 12 höurs
over two day s.
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